Development and Optimisation Using D-Optimal Design of Dual-Functionalized Hyaluronic Acid-Chitosan-Coated Mesoporous Silica Nanoparticles for Repurposed Propranolol Delivery in Breast Cancer: A Proof-of-Concept Study.

Ibrahim MS, Elsayyad NME, Noshi SH

Open source

DOI
10.1080/10837450.2026.2738747
Published
2026 Sep 24
Container
Pharmaceutical development and technology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10837450.2026.2738747,
  title = {Development and Optimisation Using D-Optimal Design of Dual-Functionalized Hyaluronic Acid-Chitosan-Coated Mesoporous Silica Nanoparticles for Repurposed Propranolol Delivery in Breast Cancer: A Proof-of-Concept Study.},
  author = {Ibrahim MS and Elsayyad NME and Noshi SH},
  year = {2026},
  journal = {Pharmaceutical development and technology},
  doi = {10.1080/10837450.2026.2738747},
  url = {https://doi.org/10.1080/10837450.2026.2738747}
}

RIS

TY  - JOUR
TI  - Development and Optimisation Using D-Optimal Design of Dual-Functionalized Hyaluronic Acid-Chitosan-Coated Mesoporous Silica Nanoparticles for Repurposed Propranolol Delivery in Breast Cancer: A Proof-of-Concept Study.
AU  - Ibrahim MS
AU  - Elsayyad NME
AU  - Noshi SH
PY  - 2026
JO  - Pharmaceutical development and technology
DO  - 10.1080/10837450.2026.2738747
UR  - https://doi.org/10.1080/10837450.2026.2738747
ER  - 

APA

MS, I., NME, E., & SH, N. (2026). Development and Optimisation Using D-Optimal Design of Dual-Functionalized Hyaluronic Acid-Chitosan-Coated Mesoporous Silica Nanoparticles for Repurposed Propranolol Delivery in Breast Cancer: A Proof-of-Concept Study.. Pharmaceutical development and technology. https://doi.org/10.1080/10837450.2026.2738747

Source records